[Nephrotoxicity of antineoplastic drugs].
Suzuki
T
T
First Department of Internal Medicine, Faculty of Medicine, University of Tokyo.
Nosaka
K
K
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced*; D008727:Methotrexate / Q000009:adverse effects; D013311:Streptozocin / Q000009:adverse effects
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D013311:Streptozocin; D003520:Cyclophosphamide; D002945:Cisplatin; D007069:Ifosfamide; D008727:Methotrexate